The information in this website is intended only for healthcare professionals. By entering this site, you are confirming that you are a healthcare professional.
The information in this website is intended only for laboratory professionals. By entering this site, you are confirming that you are a laboratory professional.
Some people have a perception of allergic disease as being a collection of rather benign, modifiable, and relatively easily controlled conditions. Though some allergies are more familiar to the general population, other conditions, along with the range and severity of the symptoms, may not be.
A structured approach to care has the opportunity to improve patient outcomes and reduce the cost of allergic diseases.1 Testing is one step in that process that has the potential to provide clinicians with the quantifiable data needed to accelerate the time to diagnosis and treatment.
Getting patients the correct diagnosis—and ultimately the appropriate treatment—relies on information from a variety of sources. An allergy-specific patient history is helpful but can only take a clinician so far in identifying the possible causative allergens. IgE is the antibody made in atopic individuals as a response to an allergen—and that triggers the release of histamine—responsible for an allergic reaction.2 Determining a patient’s level of specific IgE sensitization to common allergens can help improve certainty in your diagnosis.3
When conducting the tests ordered by clinicians to help pinpoint culpable allergies, use assays that give quantifiable, reliable results. Assays to measure IgE, that have been given marketing authorizations in many global regions, and have been extensively researched for advanced diagnosis.4 Choose from a range of assays, all of which give clinicians the accurate, clinically relevant measurements needed to develop the most appropriate management plan for their patients.5,6